Cargos activos de Ronald Bronsaer
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CellMade SAS
 CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Director Ejecutivo | 24/06/2009 | - |
| Presidente | 24/06/2009 | - | |
| Fundador | 01/01/2007 | - |
Historial de carrera de Ronald Bronsaer
Antiguos cargos conocidos de Ronald Bronsaer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CAMBREX CORPORATION | Corporate Officer/Principal | 01/01/2007 | 01/01/2007 |
Estadísticas
Internacional
| Francia | 2 |
| Estados Unidos | 2 |
Operativa
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Founder | 1 |
Sectorial
| Health Technology | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
CellMade SAS
CellMade SAS Medical SpecialtiesHealth Technology CellMade SAS develops inflammatory biomarkers for drug discovery and clinical diagnostics. The firm's services include inflammation bio bank, inflammation discovery, anti-inflammatory toxicity and companion diagnostics. Its products and services are used in a range of applications from research and development to drug screening. The company was founded by Ronald Bronsaer in 2007 and is headquartered in Marseille, France. | Health Technology |
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Ronald Bronsaer
- Experiencia
